Medtronic plc - 31 Dec 2023 Form 5 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: 10%+ Owner
Issuer ticker: OBIO
Reported as of: 31 Dec 2023
Net transaction value: $0
SEC form: 5
Accepted by SEC: 14 Feb 2024, 18:37:19 UTC
Prior SEC filing: 01 Feb 2023
Next SEC filing: 29 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Osteraas, Assistant Secretary

Key filing fact

Medtronic plc filed Form 5 for Orchestra BioMed Holdings, Inc. (OBIO) on 14 Feb 2024.

Key facts

This page summarizes Medtronic plc's Form 5 filing for Orchestra BioMed Holdings, Inc. (OBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Feb 2024, 18:37.

Change

Previous filing in this sequence was filed on 01 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock

Award

Transaction value: $0
Shares: +869,493
Change %: +17%
Price: $0.000000
Shares after: 5,868,916
Date: 13 Apr 2023
Ownership: Held by Covidien Group S.a.r.l.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares acquired by a subsidiary of the reporting person, which shares were issued as an earnout under the Agreement and Plan of Merger (the "Merger Agreement") dated effective as of July 4, 2022, by and among Orchestra BioMed Holdings, Inc., Health Sciences Acquisitions Corporation 2 ("HSAC2") and HSAC Olympus Merger Sub, Inc. (as amended, the "Merger Agreement").